Boditech Med Overview

  • Founded
  • 1998

  • Status
  • Public

  • Employees
  • 469

  • Stock Symbol
  • 206640

Stock Symbol
  • Investments
  • 4

  • Share Price
  • $6.18

  • (As of Monday Closing)

Boditech Med General Information


Boditech Med Inc is a pharmaceutical company which provides diagnostic solutions. It develops, manufactures and distributes products for in-vitro diagnostics and diagnostic reagents. The company is also developing a smart production system that integrates digital technology and IT technology. The firm develops its products for heart disease, cancer, diabetes, hormone, infection, and arthritis.

Contact Information

Formerly Known As
NH Special Purpose Acquisition 2nd Co
Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Stock Exchange
Primary Office
  • 43, Geodudanji 1-gil
  • Chuncheon, 200-883
  • South Korea

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Boditech Med Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$6.18 $6.62 $6.14 - $17.11 $139M 22.5M 179K $1.22

Boditech Med Financials Summary

In Thousands,
TTM 30-Jun-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
EV 165,566 275,682 463,010 186,723
Revenue 118,241 137,686 122,073 62,431
EBITDA 38,221 54,070 55,842 16,964
Net Income 27,725 38,734 38,527 9,991
Total Assets 146,543 161,545 149,851 87,419
Total Debt 5,433 5,769 10,931 13,799
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Boditech Med Patents

Boditech Med Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210190771-A1 Automated liquid immunoassay device and method therefor Pending 18-Dec-2019 000000000000
EP-3779441-A4 Automated liquid-phase immunoassay apparatus and method therefor Pending 19-Jul-2019
EP-3889608-A4 Tuberculosis diagnosis method and apparatus therefor Pending 27-Nov-2018 00000000000 0
US-20220011305-A1 Tuberculosis diagnosis method and apparatus therefor Pending 27-Nov-2018 00000000000
EP-3889608-A1 Tuberculosis diagnosis method and apparatus therefor Pending 27-Nov-2018 G01N33/54386
To view Boditech Med’s complete patent history, request access »

Boditech Med Board Members (1)

Name Representing Role Since
0000-0000 00000 Boditech Med Board Member 000 0000
To view Boditech Med’s complete board members history, request access »

Boditech Med Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Boditech Med Investments & Acquisitions (4)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 00000 02-Dec-2021 00000 0000 Monitoring Equipment
000 0000 0000 16-Jun-2021 00000 0000 00.00 Biotechnology
000 0000000 30-Apr-2021 0000 00000 00000 Biotechnology
Immunostics 02-Mar-2016 Merger/Acquisition 000.00 Pharmaceuticals
To view Boditech Med’s complete investments and acquisitions history, request access »

Boditech Med Subsidiaries (1)

Company Name Industry Location Founded
00000000000 Pharmaceuticals Ocean, NJ 0000
To view Boditech Med’s complete subsidiaries history, request access »